MARY MARTIN: Open Payments
NPI 1316365745 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$922 in 35 payments from 16 companies in 2025. Trend: 2023 $318 · 2024 $686 · 2025 $922
Food & beverage: $922
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $144 |
| Alnylam Pharmaceuticals Inc. | 4 | $93 |
| Boston Scientific Corporation | 3 | $93 |
| PFIZER INC. | 4 | $81 |
| SCPHARMACEUTICALS INC. | 4 | $77 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Biogen, Inc. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| CVRx, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $32 |
Products named: Leqembi, ONPATTRO, FUROSCIX, VERQUVO, VYNDAQEL, LEQVIO, VUMERITY, LUX-Dx Insertable Cardiac Monitor.
Industry payments across FL — which companies pay providers there.
